DK0623612T3 - Polymorf terazosin og farmaceutisk sammensætning - Google Patents

Polymorf terazosin og farmaceutisk sammensætning

Info

Publication number: DK0623612T3
Authority: DK; Denmark
Prior art keywords: terazosin; polymorphic; pharmaceutical composition; pharmaceutical; composition
Prior art date: 1993-04-29

Application number

DK93115607.9T

Other languages

English (en)

Inventor

Glenn A Meyer

John F Bauer

Original Assignee

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-04-29

Filing date

1993-09-28

Publication date

1996-02-05

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26733641&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0623612(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1993-09-28 Application filed by Abbott Lab filed Critical Abbott Lab

1996-02-05 Application granted granted Critical

1996-02-05 Publication of DK0623612T3 publication Critical patent/DK0623612T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

DK93115607.9T 1993-04-29 1993-09-28 Polymorf terazosin og farmaceutisk sammensætning DK0623612T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US5491793A	1993-04-29	1993-04-29
US08/090,721 US5294615A (en)	1993-04-29	1993-07-13	Terazosin polymorph and pharmaceutical composition

Publications (1)

Publication Number	Publication Date
DK0623612T3 true DK0623612T3 (da)	1996-02-05

Family

ID=26733641

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK93115607.9T DK0623612T3 (da)	1993-04-29	1993-09-28	Polymorf terazosin og farmaceutisk sammensætning

Country Status (9)

Country	Link
US (2)	US5294615A (da)
EP (1)	EP0623612B1 (da)
JP (1)	JP2755895B2 (da)
DE (1)	DE69300913T2 (da)
DK (1)	DK0623612T3 (da)
ES (1)	ES2089665T3 (da)
GR (1)	GR3018433T3 (da)
HK (1)	HK124397A (da)
MX (1)	MX9306196A (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5596109A (en) *	1992-03-24	1997-01-21	Smithkline Beecham Corporation	N-t-butyl-androst-3,5-diene-17β-carboxamide-3-carboxylic acid polymorph A
US5412095A (en) *	1993-04-29	1995-05-02	Abbott Laboratories	Terazosin monohydrochloride and processes and intermediate for its production
JPH07206857A (ja) *	1993-12-28	1995-08-08	Synthelabo Sa	アルフゾシン塩酸塩の二水和物
US5504207A (en) *	1994-10-18	1996-04-02	Abbott Laboratories	Process and intermediate for the preparation of terazosin hydrochloride dihydrate
US5587377A (en) *	1995-10-24	1996-12-24	Invamed, Inc.	Terazosin crystalline polymorph and pharmaceutical compositions thereof
DE19546573A1 (de) *	1995-12-13	1997-06-19	Uetikon Chemie Gmbh	Kristallines Polymorph von Terazosin-Hydrochlorid, sowie Verfahren zu seiner Herstellung
US5952003A (en) *	1996-08-01	1999-09-14	Novartis Corporation	Terazosin capsules
IT1286790B1 (it) *	1996-11-29	1998-07-17	Alfa Chem Ital	Processo per la produzione della forma i del terazosin monocloridrato anidro
IT1286789B1 (it) *	1996-11-29	1998-07-17	Alfa Chem Ital	Processo per la produzione della forma i del terazosin monocloridato anidro
EP0849264A1 (de) *	1996-12-20	1998-06-24	HEUMANN PHARMA GmbH	Neue polymorphe Form von doxazosinmesylat (Form I)
EP0849265A1 (de) *	1996-12-20	1998-06-24	HEUMANN PHARMA GmbH	Neue polymorphe Form von Doxazosin-Mesylat (Form II)
ES2282997T3 (es) *	1996-12-20	2007-10-16	Heumann Pcs Gmbh	Nueva forma polimorfa de mesilato e doxazosina (forma iii).
US6248888B1 (en)	1997-11-14	2001-06-19	Teva Pharmaceutical Industries Ltd.	Process for the preparation of terazosin hydrochloride dihydrate
AU4491200A (en) *	1999-08-03	2001-02-19	Lilly Icos Llc	Beta-carboline pharmaceutical compositions
US6200573B1 (en)	1999-12-03	2001-03-13	Starcor Pharmaceuticals, Inc.	Method of medical management for lower urinary tract symptoms and benign prostatic hyperplasia
DE10000792A1 (de) *	2000-01-11	2001-07-19	Bernhard C Lippold	Formulierungen von Wirkstoffen in Form einer festen Dispersion
EP1345955B1 (en) *	2000-11-17	2008-08-20	Eli Lilly And Company	Lactam dipeptide and its use in inhibiting beta-amyloid peptide release
US20030138483A1 (en) *	2001-05-25	2003-07-24	Sergio Petriconi	Soft elastic capsules and compositions thereof
US8496960B2 (en) *	2001-10-23	2013-07-30	Purdue Pharma L.P.	Terazosin transdermal device and methods
KR20040088519A (ko)	2002-02-22	2004-10-16	뉴 리버 파마슈티칼스, 인크.	활성 제제 전달 시스템 및 활성 제제의 보호 및 투여 방법
TWI353979B (en)	2002-04-10	2011-12-11	Nippon Zoki Pharmaceutical Co	Novel crystal form of 5-hydroxy-1-methylhydantoin
US7097967B2 (en) *	2002-10-24	2006-08-29	Lg Life Sciences Ltd.	Method of predicting drug-food interaction
KR20040076203A (ko) *	2003-02-24	2004-08-31	주식회사 엘지생명과학	음식물-약물 상호작용을 방지하기 위한 경구 투여용약제학적 조성물 및 방법
AU2007286186A1 (en) *	2006-08-08	2008-02-21	Auspex Pharmaceuticals, Inc.	Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects
CN102321563B (zh)	2011-10-24	2013-04-03	江南大学	一株拟无枝酸菌及利用其全细胞转化制备香草醛的方法
US9096428B2 (en) *	2013-03-08	2015-08-04	Taiwan Semiconductor Manufacturing Company, Ltd.	Methods and apparatus for MEMS structure release
US11224572B1 (en)	2020-08-17	2022-01-18	Novitium Pharma LLC	Stable oral liquid composition of terazosin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4026894A (en) *	1975-10-14	1977-05-31	Abbott Laboratories	Antihypertensive agents
GB1591490A (en) *	1977-08-04	1981-06-24	Abbott Lab	1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate
US5122514A (en) *	1990-04-23	1992-06-16	Abbott Laboratories	Psoriasis treatment
US5212176A (en) *	1990-06-29	1993-05-18	Abbott Laboratories	R(+)-terazosin
JP2652272B2 (ja) *	1990-12-31	1997-09-10	住化ファインケム株式会社	１−（４−アミノ−６，７−ジメトキシ−２−キナゾリニル）−４−（２−テトラヒドロフロイル）ピペラジン塩酸塩の新規な結晶体および該結晶体の製造方法

1993
- 1993-07-13 US US08/090,721 patent/US5294615A/en not_active Expired - Fee Related
- 1993-09-28 DK DK93115607.9T patent/DK0623612T3/da active
- 1993-09-28 ES ES93115607T patent/ES2089665T3/es not_active Expired - Lifetime
- 1993-09-28 EP EP93115607A patent/EP0623612B1/en not_active Revoked
- 1993-09-28 DE DE69300913T patent/DE69300913T2/de not_active Revoked
- 1993-10-05 MX MX9306196A patent/MX9306196A/es not_active IP Right Cessation
- 1993-10-14 JP JP5257010A patent/JP2755895B2/ja not_active Expired - Lifetime
1994
- 1994-01-06 US US08/178,184 patent/US5362730A/en not_active Expired - Fee Related
1995
- 1995-12-15 GR GR950403563T patent/GR3018433T3/el unknown
1997
- 1997-06-26 HK HK124397A patent/HK124397A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
JP2755895B2 (ja)	1998-05-25
HK124397A (en)	1997-09-12
MX9306196A (es)	1994-01-31
DE69300913D1 (de)	1996-01-11
DE69300913T2 (de)	1996-05-02
GR3018433T3 (en)	1996-03-31
EP0623612B1 (en)	1995-11-29
US5294615A (en)	1994-03-15
US5362730A (en)	1994-11-08
JPH06312984A (ja)	1994-11-08
EP0623612A1 (en)	1994-11-09
ES2089665T3 (es)	1996-10-01

Publication	Publication Date	Title
DK0623612T3 (da)	1996-02-05	Polymorf terazosin og farmaceutisk sammensætning
NO961425D0 (no)	1996-04-11	1N-alkyl-N-arylpyrimidinaminer og derivater derav
DK0623015T3 (da)	1996-12-02	Adhæsivsammensætning og fremgangsmåde
FI944832A0 (fi)	1994-10-14	Farmaseuttinen koostumus
DK1023900T3 (da)	2005-06-06	Farmaceutisk præparat indeholdende S-nitroso-lipoproteiner og anvendelse deraf
NO943763D0 (no)	1994-10-06	4-arylamino-benzopyraner og beslektede forbindelser
BR1100824A (pt)	1999-08-31	Composto e composição farmacêutica
NO931326D0 (no)	1993-04-07	Komposittprodukt og fremgangsmaate til fremstilling derav
NO307182B1 (no)	2000-02-21	Farmasoeytiske blandinger og tricykliske forbindelser
DK80593D0 (da)	1993-07-06	Fremgangsmaade og anlaeg til udvejning af genstandsportioner
BR9407048A (pt)	1996-08-13	Composiçao liquida
NO955034D0 (no)	1995-12-12	Nye substituerte 1H-imidazoler og farmasöytiske preparater inneholdende disse
NO308533B1 (no)	2000-09-25	Heteroarylaminer, anvendelse derav og farmasøytisk preparat
DK0804078T3 (da)	2000-04-10	Sammensætning og anvendelse deraf
NO931496D0 (no)	1993-04-23	Kaks-sementsammensetninger og fremgangsmaater for anvendelse derav
ITMI932540A0 (it)	1993-12-03	Composizione farmaceutica
DK0611000T3 (da)	1998-05-04	Indstilleligt kædehjul og komponenter deraf
BR9509688A (pt)	1997-09-30	Composto e composição farmacêutica
DE69416050D1 (de)	1999-03-04	Feste Zeichen-Materialzusammensetzung
LV10579A (lv)	1995-04-20	Farmaceitiska kompozicija
NO920676D0 (no)	1992-02-20	Blanding og anvendelse
NO306613B1 (no)	1999-11-29	Oligomer og farmasöytisk preparat omfattende denne
NO952766L (no)	1996-01-19	Opplösningsmiddelsammensetninger og metoder
BR9505130A (pt)	1997-09-09	Composto e composiçao farmacêutica
BR1100809A (pt)	1999-11-23	Composto e composição farmacêutica